Glucose
Decision limit
- Measured
- Glucose concentration in blood.
- Specimen
- serum or plasma
- Units
- mg/dL, mmol/L
- Companion markers
- A1c, Insulin, Connecting-segment (C) chain, Beta-hydroxybutyrate
Education First
Site section 6 of 12A lab-literacy course on panels, specimens, assays, reference frameworks, trends, confounders, bottom lines, and the relationships that connect blood work to broader biological systems.
Learning progress
Progress is private to this browser.
Formula workbench
Formulas are educational models with assumptions. Choose a formula, set the synthetic inputs, and watch which input moves which result and where the equation stops applying.
Non-HDL-C = 190 − 52mg/dL
LDL-C = 190 − 52 − 150/5mg/dL
Non-HDL-C
138mg/dL
LDL-C, Friedewald
108mg/dL
Remnant cholesterol
30mg/dL
non-HDL-C minus LDL-C
Lipid partition with synthetic inputs. Non-HDL cholesterol 138 milligrams per deciliter. LDL cholesterol by the Friedewald equation 108 milligrams per deciliter. Remnant cholesterol 30 milligrams per deciliter.
Non-HDL-C = TC − HDL-C; LDL-C = TC − HDL-C − TG/5
What it shows: Splits a synthetic total cholesterol into HDL-C, LDL-C and remnant cholesterol, with LDL-C estimated by the equation you choose.
How to read it: Move a control and read the substituted equation and the geometry in the field, and the result in the tiles. A result outside the equation’s stated use prints as not computed, with the reason.
Assumptions: All values in mg/dL. Friedewald is not applied above TG 400 mg/dL and Sampson above TG 800 mg/dL. A set that gives LDL-C at or below zero, or no remnant, is not computed. The Martin-Hopkins equation needs its published factor table and is not modeled here.
Check yourself
A learner sees one flagged marker and wants an instant health conclusion. The course has to force specimen, method, reference framework, trend, and panel context back into the decision.
Choose the next move
Pick an answer to see why.
Course spine
Most learners see panels, not isolated analytes. This course starts with context, specimen, method, and reference framework, then moves into panel clusters and systems relationships.
01 / Signals
Blood biomarkers as measured signals, not verdicts.
02 / Measurement
How specimen type, tube, timing, handling, and assay method create the number.
03 / Frameworks
How to separate reference intervals, decision limits, critical values, risk categories, and assay-specific percentiles.
04 / Panels
How grouped panels organize biology before any one marker is discussed.
05 / Systems
How marker clusters connect inflammation, insulin resistance, lipid transport, ketogenesis, kidney buffering, liver processing, thyroid tempo, oxygen transport, and coagulation.
06 / Bottom line
How to write a safe bottom line and convert uncertainty into questions for a qualified healthcare professional.
Reading workflow
The workflow prevents the common mistake of treating the red number as the answer. Context, panel identity, cluster behavior, reference framework, trend, and caveat come first.
01 / Confirm report context
Check date, fasting state, time, lab, specimen, units, medications, illness, exercise, hydration, pregnancy or menstrual context, and supplements.
02 / Identify the panel
Name the panel before naming the outlier: CBC, BMP, CMP, lipid, glycemic, kidney, liver, inflammatory, thyroid, coagulation, hormone, or specialized.
03 / Read clusters
Mark which markers belong together, then decide whether the pattern is cellular, chemical, filtration, metabolic, inflammatory, endocrine, or hemostatic.
04 / Separate frameworks
Do not mix reference intervals, decision limits, critical values, risk categories, or assay-specific percentiles.
05 / Compare like with like
Prefer prior values from the same lab and method when available, while distinguishing analytical variation from biological variation.
06 / Ask what can distort it
Check sample quality, timing, method, medications, acute illness, exercise, diet, hydration, kidney function, liver function, and RBC turnover.
07 / Write the bottom line
State what the panel can organize, what it cannot prove, what changes interpretation, and which question belongs with a qualified professional.
Lab foundations
A biomarker value is not just biology. It is specimen, tube, collection, storage, transport, method, calibration, interference, and reporting framework.
Choose a collection or handling factor to read what it can distort and the question it raises.
Choose an interference to read what it can distort inside the assay and the question it raises.
Reference frameworks
Every marker declares exactly one framework so the page does not collapse population distributions, clinical decision limits, critical communication thresholds, and assay-specific percentiles into one generic range.
Panel atlas
Each panel explains what it groups, which markers move together, common traps, missing context, cross-panel relationships, and the bottom-line framework.
Choose a panel to read what it groups, what to read first, the common traps, and the bottom line it can and cannot support.
Which cell family is changing: red cells, white cells, platelets, or a mixed pattern?
Included markers
Showing markers from Glycemic panel. Each states what is measured, specimen, units, reference framework, and companion markers. No marker here can prove a diagnosis, prognosis, treatment need, or personal health status by itself.
Decision limit
Decision limit
Assay-specific percentile
Assay-specific percentile
Systems map
The same value can be re-framed by inflammation, kidney filtration, liver processing, thyroid feedback, RBC turnover, and specimen context.
Pre-analytic factorsall markers
Specimen context precedes marker meaning.
Inflammation panelFerritin
Ferritin can represent iron stores and acute-phase context.
Glycemic panelLipid and lipoprotein panel
Energy handling can move triglyceride and HDL-C patterns.
Kidney panelA1c
Kidney and red-cell context can change A1c interpretation.
Thyroid panelLipid and lipoprotein panel
Thyroid axis context can change lipid patterns.
Liver and biliary panelInflammation panel
The liver produces several acute-phase proteins.
Ketone and acid-base panelGlycemic panel
Ketones require glucose and acid-base context.
Coagulation panelLiver and biliary panel
PT/INR can reflect clotting and liver synthetic context.
These markers require context-first teaching. The course explains why overreading is risky and routes urgency language back to the lab, clinician, or emergency instructions when symptoms or critical flags exist.
High-sensitivity troponin
Read against assay-specific cutoffs and timed repeat draws; the change between draws carries meaning that one value cannot.
D-dimer
Rises with many processes, including recent surgery, inflammation, pregnancy, and age, so it is read within a defined pretest context, never alone.
Tumor markers
Not specific to one tissue or condition and can rise in benign states; assays are not interchangeable, so a trend is read on one method.
Broad hormone panels
Pulsatile release, time of day, cycle phase, and binding proteins move values, and a wide panel multiplies chance flags.
A1c caveats
Reflects glycation over red-cell lifespan, so anemia, altered turnover, hemoglobin variants, and kidney context can shift it away from average glucose.
Ferritin caveats
An acute-phase protein as well as an iron-storage signal, so inflammation, liver context, and recent illness can raise it independently of stores.
eGFR and UACR
eGFR is an equation estimate from creatinine or cystatin C, and UACR varies day to day, so persistence needs repeat measurements.
CRP and ESR
Nonspecific inflammation signals that move with infection, injury, and many other contexts; neither names a cause.
Capstone
Each capstone asks for panel identity, clusters, missing context, what the pattern can organize, what it cannot prove, and the safe question to take to a qualified professional.
A synthetic chemistry panel has one isolated outlier and no prior trend.
No personal interpretation or self-directed action.
Synthetic glucose, A1c, triglyceride, HDL-C, ALT, and CRP pattern.
No universal screening or protocol advice.
Synthetic kidney example separates filtration estimate from albumin leak.
No kidney-disease diagnosis from the course.
Synthetic CBC indices with ferritin, B12, folate, and CRP context.
No self-supplement direction.
Synthetic recent-illness or hard-workout example with WBC, CRP, AST, and ALT movement.
No reassurance or alarm based on the course alone.
Synthetic lipid markers with missing age, blood-pressure, smoking, diabetes, family-history, and kidney context.
No personal risk calculator.
Every claim on this page points back to one of these sources.
MedlinePlus complete blood count
NLM MedlinePlus / accessed 2026-07-02
CBC plain-language panel composition.
MedlinePlus basic metabolic panel
NLM MedlinePlus / accessed 2026-07-02
BMP plain-language panel composition.
MedlinePlus comprehensive metabolic panel
NLM MedlinePlus / accessed 2026-07-02
CMP plain-language panel composition.
MedlinePlus lab-result interpretation
NLM MedlinePlus / accessed 2026-07-02
Reference range and provider-context literacy.
CDC clinical laboratory standardization
CDC / accessed 2026-07-02
Accuracy, precision, and standardization literacy.
ADA Standards of Care
American Diabetes Association / accessed 2026-07-02
Glycemic decision-limit source anchor.
AHA/ACC dyslipidemia guideline page
American Heart Association / accessed 2026-07-02
Lipid and lipoprotein risk-context source anchor.
KDIGO CKD guideline
KDIGO / accessed 2026-07-02
eGFR and albuminuria context.
American Thyroid Association thyroid function tests
American Thyroid Association / accessed 2026-07-02
Thyroid testing plain-language source anchor.
MedlinePlus C-reactive protein test
NLM MedlinePlus / accessed 2026-07-02
Inflammation marker literacy.
NCBI Bookshelf ketogenesis review
NCBI Bookshelf / accessed 2026-07-02
Ketogenesis physiology.
FDA RUO and IUO guidance
FDA / accessed 2026-07-02
Research-use boundary source.
21 CFR 809.10
eCFR / accessed 2026-07-02
In vitro diagnostic labeling boundary.
FTC health products compliance guidance
FTC / accessed 2026-07-02
Health-claim substantiation and public-copy boundary.
CLSI EP28 reference intervals
CLSI / accessed 2026-07-02
Reference-interval methodology source anchor.
CLSI EP07 interference testing
CLSI / accessed 2026-07-02
Analytical-interference methodology source anchor.
WHO blood collection guidance
WHO / accessed 2026-07-02
Specimen collection and phlebotomy context.
FDA biotin interference safety communication
FDA / accessed 2026-07-02
Biotin assay-interference source anchor.
CMS CLIA laboratory standards
CMS / accessed 2026-07-02
Clinical laboratory quality-system source anchor.
MedlinePlus cholesterol levels
NLM MedlinePlus / accessed 2026-07-02
Lipid-panel plain-language source anchor.
Course boundary
The next step is never a self-directed protocol. The next step is a clear question, prior reports, and qualified review when the pattern, persistence, symptoms, or lab flag calls for it.
Educational content only; not medical advice, diagnosis, treatment guidance, personal lab interpretation, self-triage, dosing guidance, or evidence that any catalog item changes a biological outcome. No uploads, no personal value entry, no personal lab-result reader, and no traffic-light scoring.
Editorial scope: chemical identity, experimental context, analytical methods, source quality and regulatory boundaries. Source references and stated limitations form part of the material; they should remain attached to quotations or summaries.
Lab and biomarker literacy path
Why it matters
Greater transparency today drives better research tomorrow. We provide the materials and the data so the next breakthrough is one step closer.
Our mission